We will know even more about the company's prospects in a year as it releases clinical data for various pipeline candidates.

Stanford Medicine researchers have built CRISPR-GPT, a large language model designed to automate the full arc of gene-editing ...

The field of plant biotechnology has quickly evolved with the advent of CRISPR-mediated gene editing, fundamentally transforming the exploration and ...

Current shareholders were thrown an unexpected curveball that they actually should have been expecting.

Crispr Therapeutics Ag (NASDAQ:CRSP) is one of the Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Biotech company Crispr ...

CRISPR biosensors are transforming healthcare by detecting biomarkers at attomolar sensitivity, enabling real-time health monitoring through wearable patches and implantable sensors. They continuously ...

Candy maker Mars said Wednesday it has partnered with biotech company Pairwise to speed up the development of more resilient cocoa using CRISPR-based gene editing technology. CRISPR technology is a ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Stocks Going Wild. Crispr Therapeutics rallied for a second day on Wednesday, adding 9.6 percent to close at $60.08 apiece, tracking the rally in ...

Swiss–American biotech CRISPR Therapeutics today announced the pricing of $550 million in convertible senior notes due in 2031. The notes are being offered in a private offering to qualified ...

Cathie Wood and Wall Street don't always agree. The chief executive officer of Ark Invest has been more bullish on Tesla, for example, than the general analyst community and has taken advantage of ...

When you're looking to add growth to your portfolio, you may immediately think of technology stocks -- and this is a great idea. But technology stocks aren't the only players that may supercharge your ...